139 related articles for article (PubMed ID: 27688147)
1. Bleomycin-induced skin toxicity: is it always flagellate erythema?
Verma SP; Subbiah A; Kolar Vishwanath V; Dutta TK
BMJ Case Rep; 2016 Sep; 2016():. PubMed ID: 27688147
[TBL] [Abstract][Full Text] [Related]
2. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
Behringer K; Goergen H; Hitz F; Zijlstra JM; Greil R; Markova J; Sasse S; Fuchs M; Topp MS; Soekler M; Mathas S; Meissner J; Wilhelm M; Koch P; Lindemann HW; Schalk E; Semrau R; Kriz J; Vieler T; Bentz M; Lange E; Mahlberg R; Hassler A; Vogelhuber M; Hahn D; Mezger J; Krause SW; Skoetz N; Böll B; von Tresckow B; Diehl V; Hallek M; Borchmann P; Stein H; Eich H; Engert A; ; ;
Lancet; 2015 Apr; 385(9976):1418-27. PubMed ID: 25539730
[TBL] [Abstract][Full Text] [Related]
3. Pruritic Rash in a Patient with Hodgkin's Lymphoma.
Le A; Farmakiotis D; Reagan JL
Cureus; 2018 Apr; 10(4):e2450. PubMed ID: 29888154
[TBL] [Abstract][Full Text] [Related]
4. Bleomycin-induced flagellate erythema in a patient with Hodgkin's lymphoma - A case report and review of literature.
Vennepureddy A; Siddique MN; Odaimi M; Terjanian T
J Oncol Pharm Pract; 2016 Jun; 22(3):556-60. PubMed ID: 25855241
[TBL] [Abstract][Full Text] [Related]
5. Bleomycin-induced flagellate dermatitis.
Mota GD; Penna AM; Soares RC; Baiocchi OC
Rev Bras Hematol Hemoter; 2014; 36(4):297-9. PubMed ID: 25031171
[TBL] [Abstract][Full Text] [Related]
6. Bleomycin induced flagellate erythema: Revisiting a unique complication.
Biswas A; Chaudhari PB; Sharma P; Singh L; Julka PK; Sethuraman G
J Cancer Res Ther; 2013; 9(3):500-3. PubMed ID: 24125992
[TBL] [Abstract][Full Text] [Related]
7. Bleomycin-induced flagellate erythema: A case report and review of the literature.
Lee HY; Lim KH; Ryu Y; Song SY
Oncol Lett; 2014 Aug; 8(2):933-935. PubMed ID: 25009666
[TBL] [Abstract][Full Text] [Related]
8. Primary Cutaneous Hodgkin's Lymphoma: An Extremely Rare Entity.
Hakkou D; Belefqih I; Sabri S; Dikhaye S; Bachir H; Hamaz S; Alaoui H; Serraj K
Cureus; 2021 Nov; 13(11):e19272. PubMed ID: 34881126
[TBL] [Abstract][Full Text] [Related]
9. Super-acute onset of tumor lysis syndrome accompanied by hypercytokinemia during treatment of Hodgkin's lymphoma with ABVD chemotherapy.
Suzuki T; Takeuchi M; Saeki H; Yamazaki S; Koga H; Abe D; Nishimura M; Nakaseko C; Nakasa H; Nakamura H; Ariyoshi N; Kitada M
Clin Ther; 2010 Mar; 32(3):527-31. PubMed ID: 20399989
[TBL] [Abstract][Full Text] [Related]
10. Bleomycin-induced flagellate hyperpigmentation.
Larson KN; Gagnon AL; Wilson BB
Clin Case Rep; 2017 Apr; 5(4):429-430. PubMed ID: 28396762
[TBL] [Abstract][Full Text] [Related]
11. Bleomycin-induced flagellate dermatitis.
Grynszpan R; Niemeyer-Corbellini JP; Lopes MS; Ramos-e-Silva M
BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23814202
[TBL] [Abstract][Full Text] [Related]
12. Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.
Connors JM; Klimo P; Adams G; Burns BF; Cooper I; Meyer RM; O'Reilly SE; Pater J; Quirt I; Sadura A; Shustik C; Skillings J; Sutcliffe S; Verma S; Yoshida S; Zee B
J Clin Oncol; 1997 Apr; 15(4):1638-45. PubMed ID: 9193364
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous acral nodular eruption and flagellate erythema caused by bleomycin.
Mikhail M; Eichenbaum M; Gerstenfeld E; Duquette J; Pomeranz MK; Polsky D
J Drugs Dermatol; 2005; 4(1):81-4. PubMed ID: 15696989
[TBL] [Abstract][Full Text] [Related]
14. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
[TBL] [Abstract][Full Text] [Related]
15. BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.
Diehl V; Franklin J; Hasenclever D; Tesch H; Pfreundschuh M; Lathan B; Paulus U; Sieber M; Rueffer JU; Sextro M; Engert A; Wolf J; Hermann R; Holmer L; Stappert-Jahn U; Winnerlein-Trump E; Wulf G; Krause S; Glunz A; von Kalle K; Bischoff H; Haedicke C; Duehmke E; Georgii A; Loeffler M
J Clin Oncol; 1998 Dec; 16(12):3810-21. PubMed ID: 9850026
[TBL] [Abstract][Full Text] [Related]
16. Neutropenia and febrile neutropenia in patients with Hodgkin's lymphoma treated with doxorubicin (Adriamycin), bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy.
Chand VK; Link BK; Ritchie JM; Shannon M; Wooldridge JE
Leuk Lymphoma; 2006 Apr; 47(4):657-63. PubMed ID: 16690524
[TBL] [Abstract][Full Text] [Related]
17. Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology.
Oberlin O; Leverger G; Pacquement H; Raquin MA; Chompret A; Habrand JL; Terrier-Lacombe MJ; Bey P; Bertrand Y; Rubie H
J Clin Oncol; 1992 Oct; 10(10):1602-8. PubMed ID: 1383434
[TBL] [Abstract][Full Text] [Related]
18. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.
Engert A; Plütschow A; Eich HT; Lohri A; Dörken B; Borchmann P; Berger B; Greil R; Willborn KC; Wilhelm M; Debus J; Eble MJ; Sökler M; Ho A; Rank A; Ganser A; Trümper L; Bokemeyer C; Kirchner H; Schubert J; Král Z; Fuchs M; Müller-Hermelink HK; Müller RP; Diehl V
N Engl J Med; 2010 Aug; 363(7):640-52. PubMed ID: 20818855
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
Canellos GP; Anderson JR; Propert KJ; Nissen N; Cooper MR; Henderson ES; Green MR; Gottlieb A; Peterson BA
N Engl J Med; 1992 Nov; 327(21):1478-84. PubMed ID: 1383821
[TBL] [Abstract][Full Text] [Related]
20. Consolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need?
Laskar S; Gupta T; Vimal S; Muckaden MA; Saikia TK; Pai SK; Naresh KN; Dinshaw KA
J Clin Oncol; 2004 Jan; 22(1):62-8. PubMed ID: 14657226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
